RhinoCare

RhinoCare is a medical device company specializing in respiratory solutions, developing an inhaler device for nasal congestion relief.

Health Tech & Life Sciences
Active
Pre-Funding Raanana, Israel Founded 2014
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2014
Headcount
4
HQ
Raanana, Israel
Sector
Health Tech & Life Sciences

About

RhinoCare is a medical device company that has developed and prototyped the next generation of its RhinoTherm, an inhaler device that uses hyperthermia technology from the Weizmann Institute of Science for the relief of nasal congestion symptoms. The company focuses on homecare medical devices for nasal congestion caused by rhinitis, sinusitis, colds, and flu, utilizing hyperthermia treatment with pure water at 43℃. They also employ advanced flow simulation analysis technology to predict fluid flow and heat transfer, aiming to reduce development time and enhance product performance. RhinoCare has clinically proven its effectiveness in improving nasal congestion symptoms with 990 patients from 13 institutions in 6 countries, showing improvement in 91% of patients after treatment. The company has 3 registered patents.

Funding history · 1 round · — total

2015-02
Seed Undisclosed IVC Data & Insights

Headcount over time

From 6 (2022-11) to 3 (2026-03) · -3 (-50%) · 7 points · source: Finder history + radar grounding
60 2022-11 2026-03

Q&A

What is RhinoCare's primary focus?
RhinoCare is a medical device company specializing in respiratory solutions, with a focus on heat therapy devices for treating sinus congestion.
What is RhinoCare's key product?
RhinoCare's key product is the RhinoTherm, an inhaler device designed for the relief of nasal congestion symptoms using hyperthermia technology from the Weizmann Institute of Science.
What is the current development stage of RhinoCare's RhinoTherm device?
RhinoCare has recently completed the design, development, and prototype production of the next generation of its RhinoTherm device.
When was RhinoCare founded?
RhinoCare was founded in December 2014.
Where is RhinoCare headquartered?
RhinoCare is headquartered in Herzliya, Israel.
What is RhinoCare's current funding stage?
RhinoCare is currently in the Pre-Funding stage.
Does RhinoCare hold any patents?
Yes, RhinoCare holds 1 patent.

Team · 1

Dr. Dan Shaham
Founder · Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrug Delivery
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B2C

Highlights

1 PatentsVerified

Tags

medical-devicesrespiratorydrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiterhinocarekorea.com/en
LinkedInlinkedin.com/company/83037218

Identifiers & details

Legal nameRhinoCare Ltd.
Founded2014-12
Employees (exact)4

Radar intelligence

Patents

EPO4

Web history (Wayback)

Domainrhinocarekorea.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)515171007
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2014-12-31
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events3 — annual_report (1), violation (1), charge (1)
Registered addressהמרד 8 רעננה

Recent registry events

DateEvent
2025-10-28דו~ח שנתי-הוספת בעל תפקיד
2025-09-14עדכון הפרה
2025-12-11סילוק שעבוד